These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16778308)

  • 1. Immune responses in kala-azar.
    Saha S; Mondal S; Banerjee A; Ghose J; Bhowmick S; Ali N
    Indian J Med Res; 2006 Mar; 123(3):245-66. PubMed ID: 16778308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Cytokines in the Pathogenesis of Visceral Leishmaniasis.
    Kumar R; Bhatia M; Pai K
    Clin Lab; 2017 Oct; 63(10):1549-1559. PubMed ID: 29035452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection.
    Bimal S; Sinha S; Singh SK; Narayan S; Kumar V; Verma N; Ranjan A; Sinha PK; Das VN; Pandey K; Kar SK; Das P
    Exp Parasitol; 2012 Jul; 131(3):274-82. PubMed ID: 22580024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug unresponsiveness & combination therapy for kala-azar.
    Jha TK
    Indian J Med Res; 2006 Mar; 123(3):389-98. PubMed ID: 16778318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre- & post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection.
    Sinha PK; Bimal S; Singh SK; Pandey K; Gangopadhyay DN; Bhattacharya SK
    Indian J Med Res; 2006 Mar; 123(3):197-202. PubMed ID: 16778304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine saga in visceral leishmaniasis.
    Bhor R; Rafati S; Pai K
    Cytokine; 2021 Nov; 147():155322. PubMed ID: 33127259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulator and effector functions of T-cell subsets in human Leishmania infections.
    Kemp M
    APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of T cell responsiveness in Indian kala-azar.
    Sacks DL; Lal SL; Shrivastava SN; Blackwell J; Neva FA
    J Immunol; 1987 Feb; 138(3):908-13. PubMed ID: 3100620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
    Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
    Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile.
    Ismail A; El Hassan AM; Kemp K; Gasim S; Kadaru AE; Moller T; Kharazmi A; Theander TG
    J Pathol; 1999 Dec; 189(4):615-22. PubMed ID: 10629566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.
    Bhowmick S; Ravindran R; Ali N
    Vaccine; 2007 Aug; 25(35):6544-56. PubMed ID: 17655984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serodiagnosis of leishmaniasis.
    Kar K
    Crit Rev Microbiol; 1995; 21(2):123-52. PubMed ID: 7639932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
    Mazumdar T; Anam K; Ali N
    Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.
    Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L
    Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
    Karp CL; Turco SJ; Sacks DL
    J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunology of canine leishmaniasis.
    Barbiéri CL
    Parasite Immunol; 2006 Jul; 28(7):329-37. PubMed ID: 16842269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis.
    Haldar JP; Ghose S; Saha KC; Ghose AC
    Infect Immun; 1983 Nov; 42(2):702-7. PubMed ID: 6642649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.